Katabi Maha 4
4 · Vera Therapeutics, Inc. · Filed Feb 1, 2024
Insider Transaction Report
Form 4
Katabi Maha
Director
Transactions
- Purchase
Class A Common Stock
2024-01-30$31.00/sh+161,290$4,999,990→ 3,628,446 total(indirect: By Sofinnova Venture Partners X, L.P.)
Footnotes (1)
- [F1]The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.P. ("SM X LP") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. Sofinnova Management X-A, L.L.C. ("SM X LLC") is the general partner of SVP X LP and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy and Maha Katabi are the managing members of SM X LLC and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Such entities and individuals each disclaim beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.